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Summary
Background In China, there are more than 300 million male smokers. Tobacco taxation reduces smoking-related 
premature deaths and increases government revenues, but has been criticised for disproportionately aﬀ ecting poorer 
people. We assess the distributional consequences (across diﬀ erent wealth quintiles) of a speciﬁ c excise tax on 
cigarettes in China in terms of both ﬁ nancial and health outcomes.
Methods We use extended cost-eﬀ ectiveness analysis methods to estimate, across income quintiles, the health beneﬁ ts 
(years of life gained), the additional tax revenues raised, the net ﬁ nancial consequences for households, and the 
ﬁ nancial risk protection provided to households, that would be caused by a 50% increase in tobacco price through 
excise tax fully passed onto tobacco consumers. For our modelling analysis, we used plausible values for key 
parameters, including an average price elasticity of demand for tobacco of –0·38, which is assumed to vary from 
–0·64 in the poorest quintile to –0·12 in the richest, and we considered only the male population, which constitutes 
the overwhelming majority of smokers in China.
Findings Our modelling analysis showed that a 50% increase in tobacco price through excise tax would lead to 
231 million years of life gained (95% uncertainty range 194–268 million) over 50 years (a third of which would be 
gained in the lowest income quintile), a gain of US$703 billion ($616–781 billion) of additional tax revenues from the 
excise tax (14% of which would come from the lowest income quintile, compared with 24% from the highest income 
quintile). The excise tax would increase overall household expenditures on tobacco by $376 billion ($232–505 billion), 
but decrease these expenditures by $21 billion (–$83 to $5 billion) in the lowest income quintile, and would reduce 
expenditures on tobacco-related disease by $24·0 billion ($17·3–26·3 billion, 28% of which would beneﬁ t the lowest 
income quintile). Finally, it would provide ﬁ nancial risk protection worth $1·8 billion ($1·2–2·3 billion), mainly 
concentrated (74%) in the lowest income quintile.
Interpretation Increased tobacco taxation can be a pro-poor policy instrument that brings substantial health and 
ﬁ nancial beneﬁ ts to households in China.
Funding Bill & Melinda Gates Foundation and Dalla Lana School of Public Health.
Copyright ©Verguet et al. Open access article distributed under the terms of CC BY-NC-SA.
Introduction
Many low-income and middle-income countries, such 
as China, have undergone an epidemiological transition 
from communicable to non-communicable diseases in 
recent years, which imposes a growing economic 
burden on these nations.1,2 Tobacco use is a leading 
modiﬁ able risk factor for non-communicable diseases, 
and in 2010 there were an estimated 5 million 
premature deaths attributable to smoking worldwide.3 
Asia has the highest number of tobacco users and is the 
prime target of tobacco companies.4,5 Health behavioural 
changes have accelerated rapidly in China, including 
increasingly higher numbers of cigarettes smoked in 
the already very large male smoker population.6 
Furthermore, the prevalence of smoking in women is 
still relatively low.7 In 2010, 1 million premature deaths 
were attributable to smoking in China, and the three 
leading causes of death (stroke, ischaemic heart disease, 
and chronic obstructive pulmonary disease) were 
linked to tobacco consumption.8,9
Tobacco taxation is widely recognised as very eﬀ ective 
at reducing smoking, its attributable morbidity and 
mortality,10 and subsequently the burden of non-com-
municable diseases.3,11 Additionally, it provides revenues 
and potential for redistributive health ﬁ nancing.4,12,13 Tax 
comprises about two-thirds of the retail price of cigarettes 
in most high-income countries but less than half of the 
total price in most low-income and middle-income 
countries such as China, which indicates that there is 
potential room for taxation as a ﬁ scal and health policy 
instrument.10,12,14–18
Although tobacco taxation is a cornerstone of the WHO 
Framework Convention on Tobacco Control,19 which was 
ratiﬁ ed by China in 2005, some controversy exists because 
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of the potential regressivity of excise taxes such as those 
for tobacco. This regressivity is caused by the fact that 
poor people already spend a larger proportion of their 
income on smoking than do their wealthy counterparts, 
and taxes paid by the poor would constitute a larger 
proportion of their income than that of the rich,20 which is 
a source of concern to policy makers.21 Although a given 
tobacco tax could be viewed as progressive depending on 
the speciﬁ c methods used to assess the tax burden and the 
data source used,22 most researchers conclude that tobacco 
taxes exert a negative distributional eﬀ ect. However, poor 
people are substantially more responsive to price changes 
than are their wealthy counterparts, which means that 
their consumption and tax burden could be lower,21,23–25 and 
therefore policy might reduce regressivity.
The eﬀ ect of tobacco taxation should also be considered 
alongside the fact that tobacco and tobacco-related 
disease expenditures exacerbate the eﬀ ects of poverty. 
Excessive medical spending attributable to smoking and 
consumption spending on cigarettes combined were 
estimated to impoverish 55 million Chinese people in 
the late 1990s.26 Smoking could also contribute to cycles 
of impoverishment if expenditures on education are 
displaced by those on smoking.27–30
In 2009, China launched a US$125 billion 3-year health 
reform plan, the goals of which included achievement of 
universal health coverage and prevention of medical 
impoverishment.31 Since then, impressive progress has 
been made in provision of health insurance coverage, 
resulting in narrowing of the health care access gap 
between poorer and richer individuals. However, in one 
important area—ﬁ nancial risk protection—advances still 
need to be made because insurance covers only about 
50% of inpatient costs and 30–40% of outpatient costs.31,32 
In 2011, the poorest quartile of households in China had 
about twice as much catastrophic expenditure on health 
as those in the wealthiest quartile.33
Little work has studied the distributional consequences 
of increased tobacco taxation, although the health and 
economic beneﬁ ts of such a policy could be substantial 
in Asian economies.4 Previous studies have assessed the 
policy outcomes including health beneﬁ ts, health-care 
costs, regressivity, and ﬁ nancial risk protection separately 
and with diﬀ erent analytical devices. Here, we use the 
analytical method of extended cost-eﬀ ectiveness analysis 
(ECEA)34 that can provide insights into these questions 
simultaneously in a uniﬁ ed model. We apply ECEA34–36 to 
a hypothetical excise tax that would raise the retail price 
Research in context
Evidence before this study
We did a search of PubMed using the search terms “China”, 
“tobacco”, “taxation”, “impact”, “socio-economic”, “economic 
evaluation”, “modeling”, “income inequality”, “youth”, and 
“demand” in various combinations. We did not use any 
language or date restrictions. We did the same search on Google 
Scholar. We searched resources from relevant websites, 
especially from WHO and the International Agency for Research 
on Cancer. We also consulted with experts in the specialty.
Tobacco smoking is responsible for 5 million premature deaths 
worldwide. China has the highest number of tobacco users 
(>300 million) and is a prime target of tobacco companies. The 
deleterious health and economic consequences of smoking 
have been increasingly assessed and include modelling studies 
to identify suitable interventions. Tobacco taxation is widely 
recognised to be very eﬀ ective at reducing tobacco use and 
initiation, and it provides ﬁ nancial revenues and potential for 
redistributive health ﬁ nancing. Tax comprises about two-thirds 
of the retail price of cigarettes in most high-income countries 
but less than half of the price in China, which indicates that 
there is potential room for taxation as a ﬁ scal and health policy 
instrument. Few studies have assessed the distributional 
consequences of increased excise tobacco taxes in Asian 
economies, although the health and economic beneﬁ ts of such 
a policy could be substantial.
Added value of this study
In this study, we used a uniﬁ ed analytical framework of 
extended cost-eﬀ ectiveness analysis (ECEA) that models the 
distributional consequences (across income quintiles) in China 
of an increase in tobacco price of 50% through excise tax in 
terms of the health beneﬁ ts (premature deaths averted), the 
additional tax revenues raised from excise tax, the net ﬁ nancial 
consequences for households, and the ﬁ nancial risk protection 
provided to households. We estimate substantial health gains, 
and ﬁ nd that reductions would occur in expenditures on 
tobacco-related disease, and ﬁ nancial risk protection from 
higher tobacco taxation; these beneﬁ ts would disproportionally 
favour the lower-income population quintiles. We conclude 
that higher tobacco taxation can be a pro-poor policy device 
that brings substantial health and ﬁ nancial beneﬁ ts to 
households in China.
Implications of all the available evidence
Higher tobacco taxes in China can reduce a substantial 
proportion of the global burden of smoking-related 
morbidity and mortality. Since tobacco use is a strong risk 
factor for many non-communicable diseases, for which 
health policy is still formulating in low-income and middle-
income countries, large and immediate tax increases could 
have far-reaching health benefits, lower health care costs, 
and reduced disparities in health and economic outcomes, 
especially for the poorest populations. The estimation of 
financial risk protection of tobacco control policy is an 
especially fertile topic for further studies when considered in 
conjunction with the movement towards universal health-
care coverage, which is gathering strong momentum in 
many countries. 
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of cigarettes by 50% in China. In the Chinese male 
smoking population, we estimate the distributional 
consequences (across income quintiles) of this 
hypothetical excise tax in terms of: health beneﬁ ts (years 
of life gained); additional tax revenues raised from the 
excise tax; net change in expenditures on both tobacco 
products and tobacco-related disease (eg, stroke) 
treatment; and the ﬁ nancial risk protection provided to 
households by avoiding impoverishing health-care 
expenditures.
Methods
Model
Our modelling approach draws substantially from the 
Asian Development Bank’s framework4 that estimates the 
eﬀ ect of taxation-created cigarette price shocks. It accounts 
for price responsiveness across age and socioeconomic 
groups to compare the tax burden and health gains in each 
stratum based on existing and projected numbers of future 
smokers.4 Since Chinese men comprise the vast majority 
(96%) of smokers in the country (53% of men are smokers 
vs 2% of women37), this study focuses solely on the male 
population, which we model for 50 years. The population 
is replenished as older individuals die. The population is 
divided into ﬁ ve age groups of smokers: those younger 
than 15 years of age (representing potential future 
smokers); 15–24-year-olds; 25–44-year-olds; 45–64-year-
olds; and those older than 65 years. These groups are 
further divided into income quintiles. Speciﬁ cally, these 
quintiles were deﬁ ned from four income cutoﬀ  values 
dividing the population into ﬁ ve groups (table 1).
We simulate a one-time excise tax fully passed onto 
consumers that results in the retail price of a pack of 
cigarettes increasing by 50%. We use a pre-increase tax 
rate (41% or US$0·30) and cigarette pack price (US$0·74) 
extracted from MPOWER 2011,39 to capture an average 
tax and price per pack purchased. Many diﬀ erent 
cigarette brands with a wide price range are available in 
China.15,56–58 Hence, any tax increase will only beneﬁ t poor 
people if designed to reduce the so-called switching 
down eﬀ ect to cheaper cigarette brands.3,4,10
The introduction of the excise tax has ﬁ ve main 
consequences: it reduces the number of premature 
deaths and associated years of life lost because of tobacco 
through induced smoking cessation; it brings excise tax 
revenues as tobacco price increases and cigarette 
consumption changes; it aﬀ ects the household 
expenditures on tobacco depending on the tobacco price 
increase and cigarette consumption changes; it decreases 
expenditures on the treatment of tobacco-related disease 
as a consequence of the reduction in tobacco-related 
disease burden; and it brings ﬁ nancial risk protection to 
households by preventing medical expenditures related 
to the treatment of tobacco-related disease.
First, we estimate the years of life gained as a 
consequence of the price  increase, solely among those 
who quit. We assume no health beneﬁ ts would arise from 
reduced consumption caused by price changes among 
continuing smokers. Upon quitting, smokers gain a 
particular number of years of life, depending on their age 
Value Data source
Size of male population in 
China
677 million UN data;38 authors’ assumptions
Age group (years) UN data38
<15 18%
15–24 17%
25–44 33%
45–64 24%
≥65 8%
Smoking prevalence per age 
group (%)
Asian Development Bank4 and WHO37
15–24 34%
25–44 59%
45–64 63%
≥65 40%
Relative smoking prevalence 
per income quintile
Authors’ assumptions based on 
education levels in references4,37
Income quintiles 1–4 1·14-times average per age group
Income quintile 5 (richest) 0·86-times average per age group
Cigarette consumption 
(cigarettes per day) per 
income quintile
Authors’ assumptions based on 
education levels in references4,37
Income quintile 1 (poorest) 15·6
Income quintile 2 15·5
Income quintile 3 13·8
Income quintile 4 12·7
Income quintile 5 (richest) 12·7
Price per pack of 20 cigarettes 
(2011 US$)
$0·74 (before excise tax increase),
$1·11 (after excise tax increase)
Asian Development Bank4 and WHO39
Price elasticity of demand for 
cigarette per income group
See table 3
Distribution of tobacco-
related disease mortality, by 
cause (%)
Global Burden of Disease Study 20109
Chronic obstructive 
pulmonary disease
11%
Stroke 46%
Heart disease 23%
Neoplasm 20%
Years of life gained upon 
tobacco cessation, per age 
group
Authors’ assumptions based on Asian 
Development Bank data,4 Doll et al,40 
and Jha et al41
15–24 year-olds 10 years
25–44 year-olds 9 years
45–64 year-olds 6 years
≥65 year-olds 3 years
Tobacco-related disease 
treatment costs (2011 US$)
Based on several studies42–50
Chronic obstructive 
pulmonary disease
$2078
Stroke $2024
Heart disease $10 845
Neoplasm $13 626*
(Table 1 continues on next page)
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at cessation.40 We express years of life gained as a function 
of age a at cessation. At present, China’s mean male life 
expectancy is 71 years,59 and the number of years of life 
gained is assumed to be realised 71–a after cessation. The 
number of quitters at age a is related to the participation 
elasticity, which is assumed to be half of the total price 
elasticity of demand for tobacco. In other words, we 
assume that half of price increases aﬀ ects smoking rates 
(participation elasticity), and the other half aﬀ ects the 
consumption of non-quitters. This proportion is 
consistently represented in ﬁ ndings and assumptions 
from studies over 25 years.10,25,60,61 The total price elasticity 
(hereafter referred to as the price elasticity) refers to the 
change in number of cigarettes purchased by a population 
when price changes, owing to both outright quitting and 
reduced consumption of cigarettes. The change in 
smoking-related premature mortality is the product of the 
change in price increase, the price elasticity, the net eﬀ ect 
of half this price change on smoking prevalence, and the 
life-years gained in those who quit depending on their age 
at quitting. The future smoking prevalence of those 
currently younger than 15 years of age is assumed to be 
the current prevalence rate for those aged 15–24 years. The 
model assumes that no additional smoking initiation 
occurs in those aged 15 years and older. This approach is 
conservative because the prevalence for those 15–24 years 
old is likely to rise in view of the peak for those aged 
25–44 years.62 Additionally, we assume that the price 
elasticity is twice as large in young populations (15–24-year-
olds and future smokers [ie, those <15 years old]) than in 
older smokers.4,10,61 Young smokers are generally believed 
to be more price responsive than older smokers because 
compared with older smokers they have less disposable 
income, lower addiction levels, and are more responsive 
to peer pressure.63,64 Recent reviews10,61 assessing tobacco 
use in youths showed that they can be two to three times 
more responsive to price than older people, with estimated 
price elasticities between –0·50 and –1·20 (where –0·5 
and –1·20 equal a 0·5% and 1·20% fall in demand for 
every 1% increase in price) in most high-income countries. 
Although little research has been done on youth smoking 
in low-income and middle-income countries, similar 
conclusions generally apply.10 As a case in point, results 
from the Global Youth Tobacco Survey65 suggest that the 
price elasticity might be –1·866 or even –2·2.67
Second, we estimate the additional tax revenues raised 
from the excise tax. The annual change is related to the 
change in cigarette consumption (which in turn is related 
to price elasticity), the change in excise taxes per pack 
(from US$0·30 to $0·67 here), and the number of 
smokers in a particular age group. Similarly, we estimate 
the net change in expenditures on tobacco, related to price 
elasticity, the change of price per pack (from $0·74 to 
$1·11), and the number of smokers in a given age group.
Third, we estimate the net change in expenditures on 
treatment of tobacco-related disease, following the 
reduced number of tobacco-related premature deaths. 
Value Data source
(Continued from previous page)
Use of health care by 
tobacco-related disease (%)
Based on several studies51–53 and 
authors’ assumptions
Chronic obstructive 
pulmonary disease
33%
Stroke 80%
Heart disease 81%
Neoplasm 50%
Relative use of health care per 
income quintile
Authors’ assumptions based on 
reference54
Income quintile 1 (poorest) 0·79-times average
Income quintile 2 0·98-times averages
Income quintile 3 1·00-times average
Income quintile 4 1·08-times average
Income quintile 5 (richest) 1·15-times average
Fraction of health care costs 
reimbursed by insurance 
schemes (%)
50% Authors’ assumptions based on Yip 
et al31
Individual annual income 
(2011 US$)
Income distribution based on gross 
national income per person of $4940 
and Gini coeﬃ  cient of 0·4242,55
Income quintile 1 (poorest) <$1652
Income quintile 2 $1652–3075
Income quintile 3 $3075–4850
Income quintile 4 $4850–7645
Income quintile 5 (richest) >$7645
*Note that although many neoplasms are aﬀ ected by smoking (eg, oesophageal, mouth, trachea, bronchial, and lung 
cancers), for simplicity, we associate here neoplasm treatment cost with lung cancer treatment cost because of the 
 signiﬁ cance of lung cancers among neoplasms aﬀ ected by smoking and data availability.
Table 1: Inputs used in the modelling for the tobacco excise tax increase (50% retail price increase) in China
Total Income 
quintile 1
Income 
quintile 2
Income 
quintile 3
Income 
quintile 4
Income 
quintile 5
≥65-year-olds 24 5 5 5 5 4
45–64-year-olds 97 20 20 20 20 17
25–44-year-olds 142 30 30 30 30 22
15–24-year-olds 43 9 9 9 9 7
Future smokers (ie, <15-year-olds) 43 9 9 9 9 7
Table 2: Assumed number of smokers (in millions) by age group and income quintile, before excise tax 
increase
Average Income 
quintile 1
Income 
quintile 2
Income 
quintile 3
Income 
quintile 4
Income 
quintile 5
≥65-year-olds –0·38 –0·64 –0·51 –0·38 –0·25 –0·12
45–64-year-olds –0·38 –0·64 –0·51 –0·38 –0·25 –0·12
25–44-year-olds –0·38 –0·64 –0·51 –0·38 –0·25 –0·12
15–24-year-olds –0·76 –1·28 –1·02 –0·76 –0·50 –0·24
Future smokers (ie, <15-year-olds) –0·76 –1·28 –1·02 –0·76 –0·50 –0·24
These values are the authors’ assumptions based on several studies.4,10,58,61 A price elasticity of –0·38 equals a 38% fall in 
demand for every 100% increase in price.
 Table 3: Assumed price elasticity of demand for cigarette by age group and income quintile
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The number of premature deaths averted is estimated on 
the basis of the assumption that about 50% of smokers 
die of smoking-related illness and that this risk is reduced 
upon quitting by 97% in 15–24-year-olds, 85% in 
25–44-year-olds, 75% in 45–64-year-olds, and 25% in those 
older than 65 years.4,40,41 The Global Burden of Disease 
Study 2010 classiﬁ es deaths caused by tobacco smoking 
as a risk factor among 20 possible disease outcomes 
(appendix),68 which are aggregated into the following four 
largest tobacco-related causes of death in China: stroke, 
ischaemic heart disease, chronic obstructive pulmonary 
disease, and neoplasms.9 Sub sequently, we attribute the 
share of the premature deaths averted from these four 
causes. Based on these causes, and accounting for the 
proportion of people who will seek formal health-care 
treatment (health-care use), we assign treatment-related 
costs, to which we deduce the share reimbursed by 
insurance. Although many neoplasms are aﬀ ected by 
smoking (eg, oesophageal, mouth, trachea, bronchus, 
and lung cancers), for simplicity, we associate neoplasm 
treatment cost with lung cancer treatment cost due to the 
signiﬁ cance of lung cancers in neoplasms aﬀ ected by 
smoking and data availability.
Finally, we quantify the ﬁ nancial risk protection 
provided to the households related to the reduction in the 
risk of expenditures on the treatment of tobacco-related 
disease. We use a money-metric value of insurance as our 
ﬁ nancial risk protection metric, which has been described 
elsewhere34 and is detailed in the appendix. The results 
are then aggregated by income quintile. Complete details 
of the model are given in the appendix. We used 
R statistical software (R 3.1.0) for all statistical analyses.
Model parameters
Tables 1–3 present all model key inputs. When relevant 
and where available data allow, parameter values vary by 
income quintile. For example, smoking prevalence and 
intensity (cigarettes per day) increase marginally as 
income quintile decreases.4,37 For simplicity and in view 
of the diﬃ  culty in extrapolating outcomes for the future 
in rapidly evolving China, we assume no price increases 
and no changes in household incomes and socioeconomic 
status over time after the one-time tobacco price increase.
One key driver of the analysis is the price elasticity by 
income quintile. Estimated Chinese price elasticities 
range from –0·01 to –0·8415,58,69–76 owing to variations in 
datasets and estimation methods, and as reviewed by Hu 
and colleagues15,58 can be classiﬁ ed into: high-end 
elasticities (around –0·80) as obtained from two time 
series and often cited for developing countries;10,61 middle-
range elasticities (between –0·50 and –0·60), as 
estimated in half of studies and often cited for middle-
income and high-income countries;10,61 and low-end 
elasticities (lower than –0·15), as estimated from recent 
studies.15,58 The latter elasticities could be explained by the 
wide price variation (more than ten-fold) across 
cigarettes, which enables smokers to switch to cheaper 
cigarettes without quitting, and the rising aﬀ ordability of 
cigarettes concomitant to the rapidly growing 
economy.15,56,58  In our analysis, we use –0·38 as our price 
elasticity, which corresponds to the mean elasticity from 
all studies reviewed by Hu and colleagues.15,58 In general, 
poorer populations, whether within a country or between 
countries, have higher price elasticities than do wealthier 
ones.10 We assume that the poorest income quintile is the 
most price elastic; the other quintiles are progressively 
less price elastic (based on data from Hu and colleagues58). 
See Online for appendix
Figure 1: Annual years of life gained for the tobacco excise tax increase 
(50% retail price increase) in China, over 50 years, by income quintile
0 10 20 30 40 50
0
0·5
1·0
1·5
2·0
2·5
3·0
Ye
ar
s o
f l
ife
 g
ai
ne
d 
an
nu
al
ly
 (i
n 
m
ill
io
ns
)
Years after tax increase
Poorest
Poorer
Middle
Richer
Richest
Total Income 
quintile 1
Income 
quintile 2
Income 
quintile 3
Income 
quintile 4
Income 
quintile 5
Years of life gained 
(millions)
231 
(194–268)
79 
(61 to 96)
63 
(45 to 80)
47
(30–65)
31 
(16–51)
11
(2–27)
Additional tax revenues raised from excise tax
2011 US$ billion 703 
(616–781)
98 
(60 to 142)
134 
(93 to 175)
152 
(114–187)
170 
(134–200)
149 
(119–167)
% of individual income ·· 3·87% 2·10% 1·43% 1·03% 0·65%
Change in expenditures on tobacco
2011 US$ billion 376 
(232–505)
–21* 
(–83 to 52)
40 
(–27 to 107)
89 
(27–147)
132 
(73–182)
135 
(86–164)
% of individual income ·· –0·82% 0·63% 0·84% 0·80% 0·59%
Expenditures on tobacco-related disease treatment averted
2011 US$ billion 24·0 
(17·3–26·3)
6·6 
(4·9 to 8·6)
6·9 
(3·9 to 7·5)
5·3 
(2·7–6·1)
3·7 
(1·7–5·9)
1·5 
(0·3–3·3)
% of individual income ·· 0·26% 0·11% 0·05% 0·02% <0·01%
Financial risk protection 
aﬀ orded†
(2011 US$ billion)
1·8 
(1·2–2·3)
1·3 
(0·8–1·8)
0·3 
(0·1 to 0·4)
0·1 
(0·06–0·2)
0·1 
(0·02–0·1)
<0·1 
(0·00–0·03)
95% uncertainty ranges are indicated in parentheses. *A negative value implies expenditures on tobacco averted. 
†Measured by a money-metric value of insurance.
Table 4: Cumulative results for the tobacco excise tax increase (50% retail price increase) in China, after 
50 years
For R statistical software see 
www.r-project.org
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Sensitivity analysis
To increase the robustness of our ﬁ ndings, we ﬁ rst did a 
multivariate sensitivity analysis, in which we 
simultaneously varied several key parameters (eg, price 
elasticity and treatment costs). For this purpose, we did 
Monte Carlo simulations (n=100 000 trials) to capture 
uncertainty in treatment costs, health-care use, and price 
elasticity of demand for tobacco inputs. Uncertainty was 
included by sampling n values for each parameter to 
which we assigned a beta distribution (eg, price elasticity 
and use) or a gamma distribution (eg, cost; appendix 
p 9). Finally, in the n samples, extraction of the 2·5 and 
97·5 percentiles allowed 95% uncertainty ranges (URs) 
to be established.
Second, we did univariate sensitivity analyses. We 
varied the price elasticity and set it to –0·38 across all 
income quintiles. We also varied the increase in the retail 
price of a pack of cigarettes attributable to excise tax, and 
alternatively set it to 25% (price increase from $0·74 to 
$0·92) and 100% (from $0·74 to $1·48).
Role of the funding source
The funder of the study had no role in study design or 
data collection. SV and coauthors had full access to all 
the data in the study. SV and DTJ had ﬁ nal responsibility 
for the decision to submit for publication.
Results
After 50 years of a 50% tobacco price increase in China, 
231 million years of life would be gained (95% UR 
194–268 million), of which 79 million (34%) would accrue 
to the lowest income quintile (table 4). The additional tax 
revenues raised from excise tax would be US$703 billion 
(95% UR 616–781), $98 billion (14%) of which would be 
borne by the bottom income quintile, compared with 
$149 billion (24%) in the highest income quintile and 170 
billion (21%) in the second highest income quintile 
(table 4). Total expenditures on tobacco would increase 
by about $376 billion (95% UR 232–505); however, 
these expenditures would decrease by $21 billion 
(95% UR –83 to 52) in the bottom income quintile and 
would increase in the other four income quintiles, 
ranging from US$40 billion (95% UR –27 to 107) in the 
second income quintile to $135 billion (86–164) in the 
ﬁ fth income quintile (table 4). The expenditures on 
treatment of tobacco-related disease would decrease by 
$24 billion (95% UR 17–26), $6·6 billion (27%) of which 
would be concentrated in the poorest quintile. The 
ﬁ nancial risk protection aﬀ orded would amount to about 
$1·8 billion overall (95% UR 1·2–2·3) and would also be 
concentrated ($1·3 billion [74%]) in the poorest quintile 
(table 4). Short-term results (within 10 years) are also 
given in the appendix.
The annual health gains are increasing over time 
because the younger age groups (15–24-year-olds and 
future smokers) contribute more substantially to the 
years of life gained and face a higher price elasticity than 
do older smokers (ﬁ gure 1). The annual additional tax 
revenues from excise tax decrease over time as younger 
age groups, who are more price elastic than older people, 
replace older age groups and account for the majority of 
the population. The annual additional revenues raised 
start at US$17·7 billion per year (95% UR 15·5–19·7) in 
year 1, which accounts for about 15·9% of cigarette tax 
and industry proﬁ t and 1·2% of government revenue in 
China in 2011,58,77,78 to eventually fall to $9·2 billion 
(8·0–10·3) in year 60, which represents about 8·3% of 
cigarette tax and industry proﬁ t and 0·6% of government 
revenue in China in 201158,77,78 (ﬁ gure 2). Finally, the 
annual change in expenditures on tobacco decrease over 
time as younger age groups, who are more price elastic 
Figure 2: Additional tax revenues raised by the tobacco excise tax increase 
(50% retail price increase) in China, annually, over 60 years
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Figure 3: Annual change in expenditures on tobacco, with the tobacco excise tax 
increase (50% retail price increase) in China, over 50 years, by income quintile
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than older people, replace older age groups and account 
for the majority of the population (ﬁ gure 3).
The paid out additional excise taxes represent a larger 
share of income of the low-income quintiles (3·9% and 
2·1% for the bottom and second lowest income quintiles, 
respectively), than of the higher income quintiles (1·0% 
and 0·7% for the second highest and highest income 
quintiles, respectively; table 4). In terms of expenditures 
on tobacco, the lowest income quintile sees decreases in 
expenditures, representing –0·8% of their income, by 
contrast with the two highest income quintiles that see 
increases in expenditures on tobacco of 0·8% and 0·6% 
of their incomes, respectively (table 4). Similarly, 
expenditures on tobacco-related disease averted as a 
fraction of income are higher in the bottom two quintiles 
(0·3% and 0·1%) than in the top two quintiles (0·02% at 
most). Therefore, in our base case scenario, although 
increased tobacco excise tax represents a larger share of 
income of the lower income quintiles, its other eﬀ ects 
are largely positive and beneﬁ t poor populations 
disproportionately.
By contrast, when price elasticity is held constant at 
–0·38 across all income groups, the distributional 
consequences change substantially, as would be 
expected (table 5). The health beneﬁ ts are similar 
(47 million years of life gained) across all income 
quintiles apart from the ﬁ fth (35 million years of life 
gained), in view of the fact that smoking prevalence was 
assumed to be similar across the four quintiles, except 
for the ﬁ fth quintile (the richest quintile), which has a 
lower smoking prevalence than the other quintiles. 
Additionally, the bottom two income quintiles contribute 
to the additional tax revenues to a greater extent than 
the top two quintiles (table 5). Furthermore, 
expenditures on tobacco increase for all income groups, 
with larger increases in the bottom two quintiles than 
the top two quintiles (table 5). Finally, the expenditures 
on tobacco-related disease averted are evenly distributed 
across all income groups, between US$4 and $6 billion, 
although the ﬁ nancial risk protection aﬀ orded remains 
mainly concentrated in the poorest groups. In this latter 
scenario, tobacco taxation is more regressive, and the 
diminished beneﬁ ts do not accrue as strongly to the 
lowest income groups, but nevertheless substantial 
ﬁ nancial risk protection is disproportionately achieved 
because of the decrease in tobacco-related health-care 
expenditures.
Finally, when retail price increase for a packet of 
cigarettes is set at $0·92 (25% price increase) or $1·48 
(100% price increase), the distributional consequences for 
health beneﬁ ts, expenditures on tobacco-related disease, 
and ﬁ nancial risk protection change only a little (although 
the overall changes are substantial). When cigarette packet 
retail price is $0·92, total health beneﬁ ts are reduced to 
115 million years of life gained, total expenditures on 
tobacco-related disease averted are reduced to $12·1 billion, 
and total ﬁ nancial risk protection provided to households 
falls to $0·9 billion. When retail price is $1·48, total health 
beneﬁ ts are increased to 462 million years of life gained, 
Total Income 
quintile 1
Income 
quintile 2
Income 
quintile 3
Income 
quintile 4
Income 
quintile 5
Price elasticity is set at –0·38 across all income quintiles
Years of life gained (millions) 223 47 47 47 47 35
Additional tax revenues raised 
from excise tax
2011 US$ billion 736 171 170 152 139 104
% of individual income ·· 6·77% 2·67% 1·43% 0·84% 0·45%
Change in expenditures on tobacco
2011 US$ billion 432 100 100 89 82 61
% of individual income ·· 3·97% 1·56% 0·84% 0·49% 0·26%
Expenditures on tobacco-related 
disease treatment averted
2011 US$ billion 24·9 4·1 5·2 5·3 5·7 4·6
% of individual income ·· 0·16% 0·08% 0·05% 0·03% 0·02%
Financial risk protection aﬀ orded* 
(2011 US$ billion)
1·3 0·8 0·2 0·1 0·1 <0·1
Cigarette price is set at $0·92 (retail price increase is set at 25%)
Years of life gained (millions) 115 39 31 23 16 6
Additional tax revenues raised 
from excise tax
2011 US$ billion 421 74 87 89 93 78
% of individual income ·· 2·93% 1·36% 0·84% 0·56% 0·34%
Change in expenditures on tobacco
2011 US$ billion 258 15 40 58 74 71
% of individual income ·· 0·58% 0·63% 0·55% 0·45% 0·31%
Expenditures on tobacco-related 
disease treatment averted
2011 US$ billion 12·1 3·3 3·5 2·7 1·9 0·7
% of individual income ·· 0·13% 0·05% 0·03% 0·01% <0·01%
Financial risk protection aﬀ orded* 
(2011 US$ billion)
0·9 0·7 0·1 0·1 <0·1 <0·1
Cigarette price is set at $1·48 (increase in retail price is set at 100%)
Years of life gained (millions) 462 157 126 94 62 23
Additional tax revenues raised 
from excise tax
2011 US$ billion 851 –5† 108 198 275 275
% of individual income ·· –0·21%† 1·70% 1·86% 1·66% 1·19%
Change in expenditures on tobacco
2011 US$ billion 197 –242† –80† 73 199 247
% of individual income ·· –9·6%† –1·25%† 0·68% 1·20% 1·07%
Expenditures on tobacco-related 
disease treatment averted
2011 US$ billion 48·3 13·4 13·9 10·6 7·5 2·9
% of individual income ·· 0·53% 0·22% 0·10% 0·05% 0·01%
Financial risk protection aﬀ orded* 
(2011 US$ billion)
3·6 2·6 0·6 0·2 0·1 <0·1
Three scenarios are assessed in this table: 1) price elasticity is set at –0·38 across all income quintiles (all other 
parameters remain identical as in the base case scenario); 2) increase in retail price of cigarettes is set at 25% (all other 
parameters remain identical as in the base case scenario, including price elasticity of demand for cigarette varying by 
income quintile); and 3) increase in retail price of cigarettes is set at 100% (all other parameters remain identical as in 
the base case scenario, including price elasticity of demand for cigarette varying by income quintile). *Measured by a 
money-metric value of insurance. †A negative value implies that expenditures on tobacco were averted.
Table 5: Sensitivity analysis results (cumulative) for the tobacco excise tax increase (through retail price 
increase) in China after 50 years
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total expenditures on tobacco-related disease averted to 
$48·3 billion, and total ﬁ nancial risk protection provided 
to $3·6 billion. Nonetheless, we note variations for the 
additional revenues raised from excise tax and the net 
change in expenditures on tobacco. When the price of a 
cigarette pack is $0·92, the distribution of additional tax 
revenues raised remains almost unchanged: the bottom 
quintile contributes more substantially (in terms of 
income) than the other quintiles; however, it now sees an 
increase in tobacco expenditures. When the price of a 
packet of cigarettes is $1·48, the distribution of additional 
tax revenues raised changes substantially: the lowest 
income quintile sees a decrease in excise taxes paid and a 
substantial decrease in tobacco expenditures; the second 
lowest income quintile also undergoes a decrease in 
tobacco expenditures. In the 100% price increase, tobacco 
taxation is especially progressive: all health and ﬁ nancial 
outcomes provide substantial beneﬁ t to the poorest groups.
Discussion
Tobacco tax hikes are essential in view of the increasing 
relative aﬀ ordability of tobacco.79,80 Since China’s 
economy has grown enormously, cigarettes have become 
cheaper to smokers, which means that more aggressive 
tobacco taxation is now needed.
This study assesses the distributional consequences 
on four policy-relevant outcomes of a 50% retail price 
hike on tobacco products in China. Through the use of 
plausible values for key parameters, we ﬁ nd that in a 
50-year period, in the male population, a 50% increase 
in tobacco price would lead to 231 million years of life 
gained (a third of these in the poorest group) and 
US$703 billion of additional tax revenues from excise tax 
(14% of this in the poorest group). It would increase 
overall household expenditures on tobacco by $376 
billion, but reduce these expenditures by $21 billion in 
the poorest quintile; it would also decrease expenditures 
on tobacco-related disease by $24 billion (28% of which 
would be in the poorest group). Finally, it would provide 
ﬁ nancial risk protection worth US$1·8 billion, mainly 
concentrated (74%) in the poorest households. This 
situation means that tobacco taxation can be a pro-poor 
policy instrument that brings notable health and 
ﬁ nancial beneﬁ ts to households and substantial 
revenues to society, which is especially important in the 
poor population of China, which has the highest number 
of smokers of any country worldwide.3
We also show that it is important to comprehensively 
integrate distributional aspects into analyses. We found 
that important insights into the equity of tobacco taxation 
can be otherwise missed when, as is done conventionally, 
a constant rather than an income-group-speciﬁ c price 
elasticity is used. In China, where major reforms in health 
care are being made with the aim of reducing inequalities, 
proper assessment of policy instruments might be 
diﬃ  cult unless explicit recognition of the income-speciﬁ c 
variation in tobacco demand and health-care use and 
expenditures are made. In particular, Chinese price 
variation is more than ten-fold across diﬀ erent brands of 
cigarettes15,56,58 as opposed to only about two-fold in most 
high-income countries,3 which enables smokers to switch 
down with modest consumer tax increases.80 Speciﬁ cally, 
an eﬀ ective price increase in China would need substantial 
increases in excise tax on the cheaper cigarettes3,10 to 
narrow the large gap between cheap and more expensive 
cigarettes. The Indian Government, for example, has 
recently taken on cheaper cigarettes directly by raising the 
tax on lower end cigarettes more than that on more 
expensive brands. An important consideration is the 
weighing of taxation regressivity against the health 
beneﬁ ts and ﬁ nancial risk protection resulting from 
reduced tobacco-related diseases in a consistent and 
similar framework such as here.
Our analysis has some limitations. First, uncertainty 
exists in the parameter inputs, of which the most 
important is the price elasticity of demand for tobacco. A 
wide range of elasticities has been estimated for China, 
and some studies have suggested that smokers in China 
could be quite insensitive to price changes compared with 
those in other countries.81 We chose a middle value 
among the range of values for China, and one that is close 
to the accepted value for most countries (–0·4) and that 
would probably represent true price elasticities without 
the distortion of wide price variation that exists at present 
in China.10 The wide variations in price including ﬁ ve 
classes of cigarettes58 could change the brand selection of 
some smokers. Although we did not incorporate any such 
compensating behaviour (switching to lower price of 
cigarettes), as in Hu and colleagues’ study,15 we ran a 
sensitivity analysis with a low elasticity of –0·15, and 
noted that important health, additional excise tax 
revenues, and equity gains could still be realised 
(appendix p 11). Although value-added taxes as in China’s 
tiered price system encourage smokers to switch down to 
cheaper cigarettes, speciﬁ c excise taxes as studied here 
can be designed to narrow the gap between cheap and 
expensive cigarettes to prevent smokers from swapping 
to cheaper brands.15,58,80 Furthermore, we did a multivariate 
sensitivity analysis and our results were robust with the 
uncertainty imposed.
Second, we assumed that no health beneﬁ ts would 
arise from reduced tobacco consumption because of a 
price hike among continuing smokers. Because we do 
not take into account the changes in the intensity of 
smoking, our estimates are therefore conservative. 
Similarly, we excluded female smokers from our analysis 
because they represent a small population (4% of all 
Chinese smokers37), although women’s behaviour and 
household situation might somewhat diﬀ er from that of 
men. 
Third, our epidemiological model has some 
shortcomings. For example, the non-linear harm caused 
by smoking intensity is not modelled.82 Additionally, a 
more exhaustive dynamic model with, say, age-speciﬁ c 
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mortality with and without smoking would have yielded 
a more realistic and nuanced scenario, but simplicity of 
exposition, scarcity of data, and the beneﬁ ts of 
transparency encouraged us to maintain our modelling 
approach. Furthermore, our results could have been 
discounted, treatment costs averted inﬂ ated using trends 
of the Chinese consumer price index, and individual 
incomes increased over the years with trends in the 
Chinese growth rate.42 These adjustments would have 
unnecessarily complicated the results without providing 
any additional insight. Our ﬁ nancial analysis does not 
incorporate the eﬀ ects of inﬂ ation and growth in gross 
domestic product and household income, which would 
ultimately strongly aﬀ ect the beneﬁ ts of tax increases of 
a ﬁ xed size. Neither does our model take into account 
consequences on tobacco consumers’ utility, which is in 
any case ambiguous because of an (often) simultaneous 
willingness to pay for tobacco and for aid in cessation. 
Moreover, our model could have taken the household 
disposable income or used consumption data to estimate 
standards of living, but because of data shortcomings, 
gross national income distributed in income quintiles 
based on China’s Gini coeﬃ  cient was used as a substitute 
income indicator.42,55 Likewise, we did not incorporate 
any perception of risks by individuals who smoke and 
the resulting eﬀ ect on current consumption, or lagged 
consumption responses. Taxes could indeed serve as a 
self-control device to help reduce tobacco use and enable 
successful quitting. 
Whether or not taxes are appropriately high depends in 
part on how excessively people underrate the harm from 
tobacco use.83–86 However, these issues are not well 
explored in China or other low-income and middle-
income countries, and extrapolation from studies done 
in high-income countries was judged to be inadvisable. 
Our analysis only focused on additional tax revenues 
raised from excise tax and did not estimate net 
government revenues through taxation. Since our intent 
is to take the consumer perspective, we did not model the 
Chinese tobacco tax structure. Indeed, China’s tobacco 
industry operates under a system of monopoly that is 
able not to tie tax increases to cigarette retail prices.16 
Both a central government tax (eg, value-added tax) and a 
local government tax (eg, special tobacco leaf tax) are 
collected.15,58 Hence, tobacco excise taxes will only have an 
eﬀ ect when increases are passed onto the retail price.16,80
We show that it is possible and desirable to use the 
same framework to study distributional eﬀ ects when a 
combination of outcomes related to diﬀ erent high-
priority policy objectives need to be considered. This 
study shows that, despite potentially imposing a tax 
burden on low-income groups, tobacco taxation can 
bring substantial health beneﬁ ts to poor people and can 
signiﬁ cantly reduce out-of-pocket expenditures for the 
poorest populations, especially as these lowest income 
groups are the most sensitive to increases in prices of 
tobacco products (panel). Increased tobacco taxation also 
brings signiﬁ cant ﬁ nancial risk protection to the poorest 
households through reductions in tobacco-related 
treatment expenditures. 
More than 30 years ago the World Bank argued in 
support of Chinese government policies initiated in late 
1981 to increase the retail price of cigarettes by 30%.87 
The current analysis has concluded that such policies 
are pro-poor in their ﬁ nancial as well as health 
consequences.
Contributors
SV and DTJ initiated and conceptualised the study. SV coordinated the 
research and did the analysis with CLG, SM, MM, SMM, and EDB. SV 
wrote the ﬁ rst draft of the report. RAN, KZ, PJ, and DTJ reviewed the 
report and provided advice and suggestions. SV and DTJ had ﬁ nal 
responsibility for the decision to submit for publication.
Declaration of interests
We declare no competing interests.
Acknowledgments
We thank the Bill & Melinda Gates Foundation for funding through the 
Disease Control Priorities Network grant to the University of 
Washington. We received valuable comments from Evan Blecher, 
Zachary Olson, Clint Pecenka, Nisreen Salti, Helen Saxenian, and 
Gillian Tarr. Finally, we would like to thank ﬁ ve anonymous reviewers 
for providing very valuable and constructive suggestions.
References
1 Bloom DE, Caﬁ ero E, Jané-Llopis E, et al. The global economic 
burden of non-communicable diseases (no. 8712). Program on the 
Global Demography of Aging, 2012. http://ideas.repec.org/p/gdm/
wpaper/8712.html (accessed April 20, 2014).
2 Jha P, Nugent R, Verguet S, Bloom D, Hum R. Chronic disease 
control and prevention. In: Lomborg B, ed. Global problems, smart 
solutions—costs and beneﬁ ts. Cambridge: Cambridge University 
Press, 2013.
3 Jha P, Peto R. Global eﬀ ects of smoking, of quitting, and of taxing 
tobacco. N Engl J Med 2014; 370: 60–68.
4 Asian Development Bank. Tobacco taxes: a win-win measure for 
ﬁ scal space and health. Manila: Asian Development Bank, 2012.
5 Mackay J, Ritthiphakdee B, Reddy KS. Tobacco control in Asia. 
Lancet 2013; 381: 1581–87.
6 Yang G, Kong L, Zhao W, et al. Emergence of chronic non-
communicable diseases in China. Lancet 2008; 372: 1697–705.
7 Ho MG, Ma S, Chai W, Xia W, Yang G, Novotny TE. Smoking 
among rural and urban young women in China. Tob Control 2010; 
19: 13–18.
8 Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 
1990–2010: ﬁ ndings from the Global Burden of Disease Study 2010. 
Lancet 2013; 381: 1987–2015.
9 Global Burden of Disease Study 2010. Global Burden of Disease 
Study 2010. Results by risk factor 1990–2010. Seattle: Institute for 
Health Metrics and Evaluation, 2012.
10 International Agency for Research on Cancer, World Health 
Organization. IARC handbook of cancer prevention, volume 
14: eﬀ ectiveness of tax and price policies for tobacco control. Lyon: 
World Health Organization, 2011.
11 Jamison DT, Summers LH, Alleyne G, et al. Global health 2035: a 
world converging within a generation. Lancet 2013; 382: 1898–955.
12 Chaloupka FJ, Straif K, Leon ME. Eﬀ ectiveness of tax and price 
policies in tobacco control. Tob Control 2011; 20: 235–38.
13 WHO. World Health Report 2010. Health systems ﬁ nancing: the path 
to universal coverage. Geneva: World Health Organization, 2010.
14 Jha P, Chaloupka FJ. Tobacco control in developing countries. 
New York: Oxford University Press, 2000.
15 Hu T-w, Mao Z, Shi J, Chen W. The role of taxation in tobacco 
control and its potential economic impact in China. Tob Control 
2010; 19: 58–64.
16 Gao S, Zheng R, Hu T-w. Can increases in the cigarette tax rate be 
linked to cigarette retail prices? Solving mysteries related to the 
cigarette pricing mechanism in China. Tob Control 2012; 21: 560–62.
Articles
e215 www.thelancet.com/lancetgh   Vol 3   April 2015
17 Hu T-w. Tobacco control policy analysis in China: economics and 
health. Singapore: World Scientiﬁ c Publishing Co, 2008.
18 Levy D, Rodríguez-Buño RL, Hu T-w, Moran AE. The potential 
eﬀ ects of tobacco control in China: projections from the China 
SimSmoke simulation model. BMJ 2014; 348: g1134.
19 World Health Organization. World Health Organization Framework 
Convention on Tobacco Control. http://www.who.int/fctc/en/ 
(accessed Dec 9, 2013).
20 Stiglitz J. Economics of the public sector, 3rd edn. New York: 
WW Norton & Co, 2000.
21 Warner KE. The economics of tobacco: myths and realities. 
Tob Control 2000; 9: 78–89.
22 Remler DK. Poor smokers, poor quitters, and cigarette tax 
regressivity. Am J Public Health 2004; 94: 225–29.
23 Chaloupka FJ. Rational addictive behavior and cigarette smoking, 
National Bureau of Economic Research Working Paper No. 3268. 
National Bureau of Economic Research, 1991. http://www.nber.org/
papers/w3268 (accessed April 20, 2014).
24 Townsend J, Roderick P, Cooper J. Cigarette smoking by 
socioeconomic group, sex, and age: eﬀ ects of price, income, and 
health publicity. BMJ 1994; 309: 923–27.
25 Farrelly MC, Bray JW. Response to increases in cigarette prices by 
race/ethnicity, income, and age groups—United States, 1976–1993. 
JAMA 1998; 280: 1979–80.
26 Liu Y, Rao K, Hu T-w, Sun Q, Mao Z. Cigarette smoking and poverty 
in China. Soc Sci Med 2006; 63: 2784–90.
27 Wang H, Sindelar JL, Busch SH. The impact of tobacco expenditure 
on household consumption patterns in rural China. Soc Sci Med 
2006; 62: 1414–26.
28 Xin Y, Qian J, Xu L, Tang S, Gao J, Critchley JA. The impact of 
smoking and quitting on household expenditure patterns and 
medical care costs in China. Tob Control 2009; 18: 150–55.
29 John RM, Ross H, Blecher E. Tobacco expenditures and its 
implications for household resource allocation in Cambodia. 
Tob Control 2012; 21: 341–46.
30 Hu T-w, Mao Z, Liu Y, de Beyer J, Ong M. Smoking, standard of 
living, and poverty in China. Tob Control 2005; 14: 247–50.
31 Yip W, Hsiao WC, Chen W, Hu S, Ma J, Maynard A. Early appraisal 
of China’s huge and complex health care reforms. Lancet 2012; 
379: 833–42.
32 Yip W, Hsiao WC. Non-evidence-based policy: how eﬀ ective is 
China’s new cooperative medical scheme in reducing medical 
impoverishment. Soc Sci Med 2009; 68: 201–09.
33 Meng Q, Xu L, Zhang Y, et al. Trends in access to health services 
and ﬁ nancial protection in China between 2003 and 2011: a 
cross-sectional study. Lancet 2012; 379: 805–14.
34 Verguet S, Laxminarayan R, Jamison DT. Universal public ﬁ nance 
of tuberculosis treatment in India: an extended cost-eﬀ ectiveness 
analysis. Health Econ 2015; 24: 318–32.
35 Verguet S, Murphy S, Anderson B, et al. Public ﬁ nance of rotavirus 
vaccination in India and Ethiopia: an extended cost-eﬀ ectiveness 
analysis. Vaccine 2013; 31: 4902–10.
36 Verguet S, Olson ZD, Babigumira JB, et al. Assessing pathways to 
universal health coverage in Ethiopia: health gains and ﬁ nancial 
risk protection aﬀ orded from selected interventions. 
Lancet Global Health (in press).
37 World Health Organization. Global Adult Tobacco Survey (GATS): 
China 2010 Country Report. Geneva: World Health Organization, 
2010. http://www.who.int/tobacco/surveillance/gats/en/ (accessed 
Dec 9, 2013).
38 United Nations, Department of Economic and Social Aﬀ airs, 
Population Division. http://www.un.org/en/development/desa/
population/publications/dataset/index.shtml (accessed Aug 13, 
2013). 
39 World Health Organization. MPOWER: a policy package to reverse 
the tobacco epidemic. Geneva: World Health Organization, 2011.
40 Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to 
smoking: 50 years’ observations on male British doctors. BMJ 2004; 
328: 1519.
41 Jha P, Chaloupka FJ, Moore J, et al. Tobacco addiction. In: 
Jamison DT, Breman JG, Measham AR, et al, eds. Disease control 
priorities in developing countries, 2nd edn. New York: Oxford 
University Press and the World Bank, 2006.
42 World Bank. World development indicators. http://data.worldbank.
org/data-catalog/world-development-indicators (accessed Dec 9, 2013).
43 She J, Yang P, Hong Q, Bai C. Lung cancer in China: challenges 
and interventions. Chest 2013; 143: 1117–126.
44 Le C, Zhankun S, Jun D, Keying Z. The economic burden of 
hypertension in rural south–west China. Trop Med Int Health 2012; 
17: 1544–51.
45 Lee VW, Chan WK, Lam NL, Lee KK. Cost of acute myocardial 
infarction in Hong Kong. Dis Manage Health Outcomes 2005; 
13: 281–85.
46 Wei JW, Heeley EL, Jan S, et al. Variations and determinants of 
hospital costs for acute stroke in China. PLoS One 2010; 5: e13041.
47 Ma Y, Liu Y, Fu H, et al. Evaluation of admission characteristics, 
hospital length of stay and costs for cerebral infarction in a 
medium-sized city in China. Eur J Neurol 2010; 17: 1270–76.
48 Heeley E, Anderson CS, Huang Y, et al. Role of health insurance in 
averting economic hardship in families after acute stroke in China. 
Stroke 2009; 40: 2149–56.
49 He QY, Zhou X, Xie CM, Liang ZA, Chen P, Wu CG. Impact of 
chronic obstructive pulmonary disease on quality of life and 
economic burden in Chinese urban areas. 
Zhonghua Jie He He Hu Xi Za Zhi 2009; 32: 253–57.
50 Zeng X, Karnon J, Wang S, Wu B, Wan X, Peng L. The cost of 
treating advanced non-small cell lung cancer: estimates from the 
Chinese experience. PLoS One 2012; 7: e48323.
51 Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive 
pulmonary disease in China: a large, population-based survey. 
Am J Respir Crit Care Med 2007; 176: 753–60.
52 Zhao D, Liu J, Wang W, et al. Epidemiological transition of stroke in 
China twenty-one-year observational study from the Sino-MONICA-
Beijing project. Stroke 2008; 39: 1668–74.
53 Chai Y, Xu H, Wang W, et al. A survey of factors associated with the 
utilization of community health centers for managing hypertensive 
patients in Chengdu, China. PLoS One 2011; 6: e21718.
54 Shanghai Municipal Center for Disease Control & Prevention 
(SCDC). Study on global AGEing and adult health (SAGE), Wave 1. 
China National Report. Study Report October, 2012. http://apps.
who.int/healthinfo/systems/surveydata/index.php/catalog/13/
download/1874 (accessed April 23, 2014).
55 Salem ABZ, Mount TD. A convenient descriptive model of income 
distribution: the gamma density. Econometrica 1974; 42: 1115–27.
56 Chinese Center for Disease Control and Prevention. Global adult 
tobacco survey (GATS) China 2010 country report. http://www.who.
int/tobacco/surveillance/survey/gats/en_gats_china_report.pdf 
(accessed Dec 29, 2014).
57 Shang C, Chaloupka FJ, Zahra N, Fong GT. The distribution of 
cigarette prices under diﬀ erent tax structures: ﬁ ndings from the 
International Tobacco Control Policy Evaluation (ITC) project. 
Tob Control 2013; DOI:10.1136/tobaccocontrol-2013-050966.
58 Hu T-w, Mao Z, Shi J, Chen W. Tobacco taxation and its potential 
impact in China. Paris: International Union Against Tuberculosis 
and Lung Disease, 2008.
59 World Health Organization. Life tables. Global Health Observatory. 
http://www.who.int/gho/mortality_burden_disease/life_tables/life_
tables/en/ (accessed Dec 9, 2013).
60 Gallet CA, List JA. Cigarette demand: a meta-analysis of elasticities. 
Health Econ 2003; 12: 821–35.
61 World Health Organization. WHO technical manual on tobacco tax 
administration. Geneva: World Health Organization, 2010.
62 Jha P, Jacob B, Gajalakshmi V, et al. A nationally representative 
case-control study of smoking and death in India. N Engl J Med 
2008; 358: 1137–47.
63 Grossman M, Chaloupka FJ. Cigarette taxes, the straw to break the 
camel’s back. Public Health Reports 1997; 112: 291–97.
64 Lewit EM, Coate D, Grossman M. The eﬀ ects of government 
regulation on teenage smoking. J Law Econ 1981; 24: 545–49.
65 Global Youth Tobacco Survey Collaborative Group. Global Youth 
Tobacco Survey. http://www.who.int/tobacco/surveillance/gyts/en/ 
(accessed Dec 9, 2013).
66 Kostova D, Ross H, Blecher E, Markowitz S. Prices and cigarette 
demand: evidence from youth tobacco use in developing countries. 
National Bureau of Economic Research Working Paper no.15781. 
Cambridge, MA: National Bureau of Economic Research, 2010.
Articles
www.thelancet.com/lancetgh   Vol 3   April 2015 e216
67 Nikaj S, Chaloupka FJ. The eﬀ ect of prices on cigarette use among 
youths in the Global Youth Tobacco Survey. Nicotine Tob Res 2013; 
published online May 24. DOI: 10.1093/ntr/ntt019.
68 Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of 
burden of disease and injury attributable to 67 risk factors and risk 
factor clusters in 21 regions, 1990–2010: a systematic analysis for 
the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224–60.
69 Mao ZZ, Jiang JL. Demand for cigarette and pricing policy [in 
Chinese]. Chinese Health Economics 1997; 16: 50–52.
70 Hu T-w, Mao ZZ. Eﬀ ects of cigarette tax on cigarette consumption 
and the Chinese economy. Tob Control 2002; 11: 105–08.
71 Mao ZZ, Hu T-w, Yang GH. New estimate of the demand for 
cigarettes in China. Chin J Health Econ 2005; 24: 45–47 [in Chinese].
72 Bai Y, Zhang Z. Aggregate cigarette demand and regional 
diﬀ erences in China. Appl Econ 2005; 37: 2523–28.
73 Mao ZZ, Jiang JL. Determinants of the demand for cigarettes: 
a cross-sectional study. Chin Health Service Management 1997; 
13: 227–29 [in Chinese].
74 Mao ZX, Yang GH, Ma H. Adults’ demand for cigarettes and its 
determinants in China. Soft Sci Health 2003; 17: 19–23 [in Chinese].
75 Mao ZZ, Hu T-w, Yang GH. Price elasticities and impact of tobacco 
tax among various income groups [in Chinese]. 
Chin J Evidence-Based Med 2005; 5: 291–95.
76 Kostova D, Chaloupka FJ, Yurekli A, et al. A cross-country study of 
cigarette prices and aﬀ ordability: evidence from the Global Adult 
Tobacco Survey. Tob Control 2014; 23: e3.
77 China Statistical Yearbook, 1989–2014. Beijing: China National 
Bureau of Statistics, 2014.
78 China Tobacco Statistics Yearbook, 1989–2014. Beijing: China 
National Tobacco Company, 2014.
79 Blecher EH, Van Walbeek CP. Cigarette aﬀ ordability trends: an 
update and some methodological comments. Tob Control 2009; 
18: 167–75.
80 White JS, Li J, Hu T-w, Fong GT, Jiang Y. The eﬀ ect of cigarette 
prices on brand-switching in China: a longitudinal analysis of data 
from the ITC China Survey. Tob Control 2014; 23: i54–60.
81 Lance PM, Akin JS, Dow WH, Loh C-P. Is cigarette smoking in 
poorer nations highly sensitive to price? Evidence from Russia and 
China. J Health Econ 2004; 23: 173–89.
82 Schane RE, Ling PM, Glantz SA. Health eﬀ e cts of light and 
intermittent smoking: a review. Circulation 2010; 121: 1518–22.
83 Cherukupalli R. A behavioral economics perspective on tobacco 
taxation. Am J Public Health 2010; 100: 609–15.
84 Gruber J, Kőszegi B. Is addiction “rational”? Theory and evidence. 
Q J Econ 2001; 116: 1261–303.
85 Gruber J, Mullainathan S. Do cigarette taxes make smokers 
happier? Top Econ Anal Pol 2005; 5: 1538–653.
86 Gruber J, Kőszegi B. A modern economic view of tobacco taxation. 
Paris: International Union Against Tuberculosis and Lung Disease, 
2008.
87 Jamison DT, Evans JR, King T, Porter I, Prescott N, Prost A. China, 
The Health Sector. Washington, DC: The World Bank, 1984.
